Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Enzo Biochem Inc. (ENZ)

-NYSE

2.23 Down 0.01(0.45%) 4:06PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJan 30, 2013Oct 30, 2012Jul 30, 2012Apr 29, 2012
Total Revenue 22,209   25,630   26,410   25,948  
Cost of Revenue13,568  13,894  14,734  13,894  
Gross Profit 8,641   11,736   11,676   12,054  
Operating Expenses
Research Development968  1,011  1,377  1,588  
Selling General and Administrative10,893  11,415  12,201  11,855  
Non Recurring2,777  3,294  26,885  2,136  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (5,997) (3,984) (28,787) (3,525)
Income from Continuing Operations
Total Other Income/Expenses Net145  229  (287)80  
Earnings Before Interest And Taxes(5,852)(3,755)(29,074)(3,445)
Interest Expense -   -   -   -  
Income Before Tax(5,852)(3,755)(29,074)(3,445)
Income Tax Expense(178)(64)(1,931)(34)
Minority Interest -   -   -   -  
Net Income From Continuing Ops(5,674)(3,691)(27,143)(3,411)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (5,674) (3,691) (27,143) (3,411)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (5,674) (3,691) (27,143) (3,411)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.